Search by Drug Name or NDC

    NDC 00002-8233-05 Insulin Lispro Protamine and Insulin Lispro Injectable Suspension 100 [iU]/mL Details

    Insulin Lispro Protamine and Insulin Lispro Injectable Suspension 100 [iU]/mL

    Insulin Lispro Protamine and Insulin Lispro Injectable Suspension is a SUBCUTANEOUS INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is INSULIN LISPRO.

    Product Information

    NDC 00002-8233
    Product ID 0002-8233_7a32de8b-9b84-4dd7-829b-5a300cca8331
    Associated GPIs 2710408000D320
    GCN Sequence Number 042076
    GCN Sequence Number Description insulin lispro protamin/lispro INSULN PEN 75-25/ML SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 93717
    HICL Sequence Number 019949
    HICL Sequence Number Description INSULIN LISPRO PROTAMINE AND INSULIN LISPRO
    Brand/Generic Generic
    Proprietary Name Insulin Lispro Protamine and Insulin Lispro Injectable Suspension
    Proprietary Name Suffix Mix75/25 KwikPen
    Non-Proprietary Name Insulin lispro
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SUSPENSION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN LISPRO
    Labeler Name Eli Lilly and Company
    Pharmaceutical Class Insulin Analog [EPC], Insulin [Chemical/Ingredient]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA021017
    Listing Certified Through 2024-12-31

    Package

    NDC 00002-8233-05 (00002823305)

    NDC Package Code 0002-8233-05
    Billing NDC 00002823305
    Package 5 SYRINGE in 1 CARTON (0002-8233-05) / 3 mL in 1 SYRINGE (0002-8233-01)
    Marketing Start Date 2020-02-12
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 10.1667
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description INSULIN LISPRO MIX 75-25 KWKPN
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5, 6
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis